Literature DB >> 25884064

New agents for hyperkalemia.

David K Packham, Henrik S Rasmussen, Bhupinder Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25884064     DOI： 10.1056/NEJMc1501933

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemia.

Authors:  Shilpa Vijayakumar; Javed Butler; George L Bakris
Journal:  Eur Heart J Suppl       Date:  2019-02-26       Impact factor: 1.803

2.  Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain.

Authors:  Antonio Olry de Labry Lima; Óscar Díaz Castro; Jorge M Romero-Requena; M de Los Reyes García Díaz-Guerra; Virginia Arroyo Pineda; M Belén de la Hija Díaz; Meritxell Ascanio; Josep Darbà; Josep M Cruzado
Journal:  Clin Kidney J       Date:  2021-04-07

Review 3.  Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options.

Authors:  Enrique Morales; Paolo Cravedi; Joaquin Manrique
Journal:  Front Med (Lausanne)       Date:  2021-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.